AstraZeneca Aktie
171,85
EUR
+1,95
EUR
+1,15
%
204,25
USD
-0,51
USD
-0,25
%
Werbung
AstraZeneca Aktie Analyse
| 18.01.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.01.23 | AstraZeneca Buy | Deutsche Bank AG | |
| 11.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.01.23 | AstraZeneca Overweight | Barclays Capital | |
| 09.01.23 | AstraZeneca Neutral | UBS AG | |
| 06.01.23 | AstraZeneca Neutral | Credit Suisse Group | |
| 05.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 05.01.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.12.22 | AstraZeneca Overweight | Barclays Capital | |
| 15.12.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.12.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.12.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.12.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 14.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 11.11.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.11.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.11.22 | AstraZeneca Neutral | UBS AG | |
| 10.11.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.11.22 | AstraZeneca Overweight | Barclays Capital | |
| 27.10.22 | AstraZeneca Overweight | Barclays Capital | |
| 26.10.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.10.22 | AstraZeneca Neutral | Credit Suisse Group | |
| 19.10.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.10.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 07.10.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.10.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 05.10.22 | AstraZeneca Neutral | Credit Suisse Group | |
| 22.09.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 21.09.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.09.22 | AstraZeneca Neutral | Credit Suisse Group | |
| 15.09.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.09.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 09.09.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 08.09.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.08.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.08.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.08.22 | AstraZeneca Overweight | Barclays Capital | |
| 01.08.22 | AstraZeneca Outperform | Credit Suisse Group | |
| 01.08.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 18.07.22 | AstraZeneca Overweight | Barclays Capital | |
| 14.07.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 14.07.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 13.07.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.07.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.07.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.07.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 14.06.22 | AstraZeneca Neutral | UBS AG | |
Werbung
Werbung